Page last updated: 2024-12-09

s18986-1

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

S18986-1: a positive AMPA receptor modulator [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID637863
CHEMBL ID320642
SCHEMBL ID6622911
MeSH IDM0370993

Synonyms (31)

Synonym
CHEMBL320642
(3as)-2,3,3a,4-tetrahydro-1h-pyrrolo[2,1-c][1,2,4]benzothiadiazine 5,5-dioxide
s 18986
175340-20-2
ia262432y9 ,
unii-ia262432y9
s18986-1
s 18986-1
s18986 ,
(s)-2,3-dihydro-(3,4)cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide
s-18986
(6s)-8$l^{6}-thia-2,7-diazatricyclo[7.4.0.0^{2,6}]trideca-1(9),10,12-triene-8,8-dione
gtpl4304
(3as)-2,3,3a,4-tetrahydro-1h-pyrrolo(2,1-c)(1,2,4)benzothiadiazine 5,5-dioxide
(+)-s-18986
s 18986 [who-dd]
1h-pyrrolo(2,1-c)(1,2,4)benzothiadiazine, 2,3,3a,4-tetrahydro-, 5,5-dioxide, (3as)-
SCHEMBL6622911
(3as)-5,5dioxo-2,3,3a,4-tetrahydro-1h-pyrrolo[2,1-c][1,2,4]benzothiadiazine
MNTIJYGEITVWHU-SNVBAGLBSA-N ,
AKOS024457867
(+)-(s)-2,3,3a,4-tetrahydro-1h-pyrrolo[2,1-c][1,2,4]benzothiadiazine-5,5-dioxide
(3as)-2,3,3a,4-tetrahydro-1h-pyrrolo[2,1-c][1,2,4]benzothiadiazine-5,5-dioxide
EX-A818
Q5552687
CS-0002898
HY-10936
DTXSID40938656
cid 637863
(6s)-8|e?-thia-2,7-diazatricyclo[7.4.0.0?,?]trideca-1(9),10,12-triene-8,8-dione
E98691

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Cerebrospinal fluid and brain tissue concentrations were determined using a conventional pharmacokinetic approach."( Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat.
Bernard, K; Bourasset, F; Genissel, P; Muñoz, C; Scherrmann, JM, 2005
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID291181Activity at Wistar rat cortex AMPA receptor expressed in Xenopus laevis oocytes assessed as maximum increase of (S)-AMPA-induced current2007Journal of medicinal chemistry, Jun-28, Volume: 50, Issue:13
Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
AID291179Activity at Wistar rat cortex AMPA receptor expressed in Xenopus laevis oocytes assessed as 5-fold increase of (S)-AMPA-induced current2007Journal of medicinal chemistry, Jun-28, Volume: 50, Issue:13
Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
AID345811Potentiation of Wistar rat AMPA receptor expressed in Xenopus laevis oocytes assessed as 2-fold increase in amplitude of (S)-AMPA-induced current by two electrode voltage-clamp method2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators.
AID345813Potentiation of Wistar rat AMPA receptor expressed in Xenopus laevis oocytes assessed as increase in amplitude of (S)-AMP-induced current by two electrode voltage-clamp method relative to AMPA2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators.
AID291183Increase in (S)-AMPA-stimulated [3H]noradrenaline release in Wistar rat hippocampus at 30 uM relative to control2007Journal of medicinal chemistry, Jun-28, Volume: 50, Issue:13
Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
AID458611Induction of amplitude current in Xenopus laevis oocytes assessed as 2 fold increase in AMPA-induced current by voltage clamp method2010Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4
New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors.
AID458612Induction of membrane depolarization in rat E16 cells assessed as 2 fold increase in AMPA-induced fluorescence by flipR method2010Journal of medicinal chemistry, Feb-25, Volume: 53, Issue:4
New fluorinated 1,2,4-benzothiadiazine 1,1-dioxides: discovery of an orally active cognitive enhancer acting through potentiation of the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid receptors.
AID291180Activity at Wistar rat cortex AMPA receptor expressed in Xenopus laevis oocytes assessed as effect on (S)-AMPA-induced current2007Journal of medicinal chemistry, Jun-28, Volume: 50, Issue:13
Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
AID345812Potentiation of Wistar rat AMPA receptor expressed in Xenopus laevis oocytes assessed as 5-fold increase in amplitude of (S)-AMPA-induced current by two electrode voltage-clamp method2008Bioorganic & medicinal chemistry, Dec-01, Volume: 16, Issue:23
Synthesis and pharmacological evaluation of a second generation of pyridothiadiazine 1,1-dioxides acting as AMPA potentiators.
AID291178Activity at Wistar rat cortex AMPA receptor expressed in Xenopus laevis oocytes assessed as 2-fold increase of (S)-AMPA-induced current2007Journal of medicinal chemistry, Jun-28, Volume: 50, Issue:13
Design, synthesis, and pharmacology of novel 7-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides as positive allosteric modulators of AMPA receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (73.68)29.6817
2010's5 (26.32)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.11 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]